Sandbox: m: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" |valign=top| |+ ! style="background: #4479BA; width: 250px; color: #FFFFFF;"|'''Prognostic Factor''' ! styl...")
 
No edit summary
Line 1: Line 1:
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px"
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px"
|valign=top|
|valign=top|
|+
|+ '''Cardiac Myxoma'''
! style="background: #4479BA; width: 250px; color: #FFFFFF;"|'''Prognostic Factor'''
! style="background: #4479BA; width: 200px; color: #FFFFFF;"|'''Features'''


! style="background: #4479BA; width: 600px; color: #FFFFFF;"|'''Description'''
! style="background: #4479BA; width: 600px; color: #FFFFFF;"|'''Description'''
Line 8: Line 8:
|-
|-


| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Age'''|| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''General aspects'''|| style="padding: 5px 5px; background: #F5F5F5;" |
:* Older age at the time of diagnosis is associated with a worse prognosis.
:* Older age at the time of diagnosis is associated with a worse prognosis.


|-
|-


| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Gender'''|| style="padding: 5px 5px; background: #F5F5F5;"|
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Genetics'''|| style="padding: 5px 5px; background: #F5F5F5;"|
:* Males are associated with a worse prognosis when compared to females.
:* Males are associated with a worse prognosis when compared to females.
|-
|-




| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Performance status'''|| style="padding: 5px 5px; background: #F5F5F5;"|
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Gross Pathology'''|| style="padding: 5px 5px; background: #F5F5F5;"|
:* Patient's poor [[performance status]] is associated with a worse prognosis.
:* Patient's poor [[performance status]] is associated with a worse prognosis.
|-
|-


| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Stage'''|| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Micropathology'''|| style="padding: 5px 5px; background: #F5F5F5;" |
:*Binet stages B and C or Rai stages 2-4 are associated with a worse prognosis.
:*Binet stages B and C or Rai stages 2-4 are associated with a worse prognosis.


|-
|-


| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Lymphocyte doubling time'''|| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Inmunohistochemistry'''|| style="padding: 5px 5px; background: #F5F5F5;" |
:*A rapid [[lymphocyte]] doubling time is associated with a worse prognosis.
:*A rapid [[lymphocyte]] doubling time is associated with a worse prognosis.




|}
|}

Revision as of 21:36, 23 November 2015

Cardiac Myxoma
Features Description
General aspects
  • Older age at the time of diagnosis is associated with a worse prognosis.
Genetics
  • Males are associated with a worse prognosis when compared to females.
Gross Pathology
Micropathology
  • Binet stages B and C or Rai stages 2-4 are associated with a worse prognosis.
Inmunohistochemistry
  • A rapid lymphocyte doubling time is associated with a worse prognosis.


Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:_m&oldid=1189864"